Novo Holdings, the major shareholder of Danish pharmaceutical company Novo Nordisk (NYSE:NVO), plans to ramp up its annual investments to $7 billion by 2030. What Happened: The investment firm, which manages the assets of the Novo Nordisk Foundation, intends to increase its annual investments from $3 billion in 2023 to $7 billion by 2030. This surge is attributed to the rising dividends from its 28% stake in Novo Nordisk and other investments, reported Financial Times on Sunday. Novo Holdings’ CEO, Kasim Kutay, highlighted that the increasing income from its investments and the success of Novo…
